Anna M Szpurka

Executive Director - Clinical Biomarker Development

Role
Executive Director at Eli Lilly and Company
Location
Indianapolis, IN, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

Experience

  1. Executive Director

    Eli Lilly and Company

    Sep 2025 — Present

Education

  • Medical University of Warsaw - MUW

    PhD, Medical Biology

  • Uniwersytet im. Adama Mickiewicza w Poznaniu

    BS, Biotechnology

  • Uniwersytet im. Adama Mickiewicza w Poznaniu

    MSc, Biotechnology

Skills

  • Sequencing
  • Biochemistry
  • Arrays
  • Cell Culture
  • Translational Research
  • Assay Development
  • Protein Expression
  • Clinical Trials
  • Elisa
  • Animal Models
  • Molecular Biology
  • Cell
  • Flow Cytometry
  • Translational Medicine
  • Hematology
  • Epigenetics
  • In Vitro
  • Genomics
  • Clinical Research
  • Oncology
  • Gene Therapy
  • Cancer Research
  • Western Blotting
  • Cancer
  • Genetics
  • Biomarkers

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Anna M Szpurka — Executive Director at Eli Lilly and Company in Indianapolis, IN, US | Unifers